Pricing Log in Create free account

Conexeu Sciences Inc. (CNXU) vs MediciNova, Inc. (MNOV)

Conexeu Sciences Inc. and MediciNova, Inc. are both Biotechnology companies. Conexeu Sciences Inc. and MediciNova, Inc. are of similar size ($71.4M and $65.4M). Conexeu Sciences Inc. has the higher net margin (0.00% vs −1,168.3%) and the lower return on invested capital (−234.6% vs −62.5%). Across the 12 metrics below, MediciNova, Inc. leads on 8 and Conexeu Sciences Inc. on 4.

Valuation

Metric CNXU MNOV Biotechnology median
P/E n/m n/m 10.26
P/S n/m 77.54 9.18
P/B 9.64 1.91 2.05
Price to free cash flow n/m n/m 24.81
EV/EBITDA n/m n/m 0.65
EV/Sales n/m 49.93 8.98
Earnings yield (29.81%) (14.48%) (34.89%)
Free cash flow yield (18.82%) (12.78%) (24.52%)

Profitability

Metric CNXU MNOV Biotechnology median
Gross margin — 37.76% 65.16%
Operating margin 0.00% (1,287.53%) 0.00%
Net margin 0.00% (1,168.31%) 0.00%
Free cash flow margin 0.00% (991.31%) 0.00%
Return on equity (458.40%) (25.56%) (50.12%)
Return on assets (354.37%) (23.83%) (45.60%)
Return on invested capital (234.60%) (62.48%) 0.00%

Growth

Metric CNXU MNOV Biotechnology median
Revenue growth (TTM) — (82.20%) 6.26%
EPS growth (last fiscal year) (342.80%) (4.35%) 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric CNXU MNOV Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 5.31 8.75 4.89
Net debt to EBITDA 1.23 2.32 1.01

Dividend

Metric CNXU MNOV Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric CNXU MNOV Biotechnology median
Market cap 65.36m 71.37m 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack